Two Sigma Investments’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$75.2M Buy
1,545,966
+356,807
+30% +$17.4M 0.13% 197
2025
Q1
$40.5M Buy
1,189,159
+882,887
+288% +$30M 0.09% 277
2024
Q4
$12.1M Buy
306,272
+127,219
+71% +$5.01M 0.03% 631
2024
Q3
$8.41M Buy
179,053
+161,994
+950% +$7.61M 0.02% 797
2024
Q2
$921K Sell
17,059
-31,999
-65% -$1.73M ﹤0.01% 1960
2024
Q1
$3.34M Sell
49,058
-35,973
-42% -$2.45M 0.01% 1135
2023
Q4
$5.32M Sell
85,031
-134,756
-61% -$8.44M 0.01% 901
2023
Q3
$9.98M Sell
219,787
-213,284
-49% -$9.68M 0.03% 570
2023
Q2
$24.3M Buy
433,071
+217,037
+100% +$12.2M 0.06% 333
2023
Q1
$9.77M Buy
216,034
+174,303
+418% +$7.88M 0.03% 565
2022
Q4
$1.7M Sell
41,731
-70,357
-63% -$2.86M 0.01% 1356
2022
Q3
$7.33M Buy
112,088
+66,663
+147% +$4.36M 0.02% 588
2022
Q2
$2.76M Sell
45,425
-272,949
-86% -$16.6M 0.01% 984
2022
Q1
$20M Buy
318,374
+105,790
+50% +$6.64M 0.06% 379
2021
Q4
$16.1M Buy
212,584
+207,310
+3,931% +$15.7M 0.03% 485
2021
Q3
$590K Sell
5,274
-425,751
-99% -$47.6M ﹤0.01% 1941
2021
Q2
$69.8M Sell
431,025
-707,083
-62% -$114M 0.16% 139
2021
Q1
$139M Buy
1,138,108
+856,873
+305% +$104M 0.36% 48
2020
Q4
$43.1M Buy
281,235
+42,724
+18% +$6.54M 0.12% 177
2020
Q3
$19.9M Buy
238,511
+120,863
+103% +$10.1M 0.07% 266
2020
Q2
$8.65M Sell
117,648
-111,741
-49% -$8.21M 0.04% 378
2020
Q1
$9.73M Sell
229,389
-229,617
-50% -$9.74M 0.08% 210
2019
Q4
$28M Buy
459,006
+362,978
+378% +$22.1M 0.08% 259
2019
Q3
$3.94M Buy
96,028
+62,628
+188% +$2.57M 0.01% 708
2019
Q2
$1.57M Sell
33,400
-42,912
-56% -$2.02M 0.01% 1178
2019
Q1
$2.73M Sell
76,312
-433,260
-85% -$15.5M 0.01% 1026
2018
Q4
$14.6M Buy
509,572
+102,478
+25% +$2.93M 0.06% 397
2018
Q3
$18.1M Buy
407,094
+354,254
+670% +$15.7M 0.05% 412
2018
Q2
$3.11M Sell
52,840
-51,958
-50% -$3.05M 0.01% 912
2018
Q1
$4.79M Buy
104,798
+58,824
+128% +$2.69M 0.02% 743
2017
Q4
$1.08M Buy
+45,974
New +$1.08M ﹤0.01% 1433